|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Furthermore, we will elaborate on the role of adiponectin isoforms as inflammatory proteins with respect to cardiac and kidney disease and discuss the association of adiponectin with mortality.
|
29655459 |
2019 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
|
30557306 |
2018 |
|
Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Adiponectin expression in renal corpuscles was significantly higher in humans with known renal diseases.
|
29207395 |
2017 |
|
Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Adiponectin levels in type 2 diabetics also negatively correlate with early features of nephropathy.
|
24417947 |
2014 |
|
Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes.
|
24894086 |
2014 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Low levels of the adipocyte-secreted protein adiponectin correlate with albuminuria in both mice and humans, but whether adiponectin has a causative role in modulating renal disease is unknown.
|
23334396 |
2013 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
However, although kidney disease is associated with insulin resistance, adiponectin is elevated in end-stage renal disease.
|
23283133 |
2013 |
|
Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.
|
20667095 |
2010 |
|
Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The adiponectin promoter single nucleotide polymorphism (SNP) -11391G/A is found to be associated with nephropathy in type 1 diabetic (T1D) patients among Danish, but not French, Finnish, and Swedish populations.
|
18599322 |
2009 |
|
Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy.
|
19056609 |
2009 |
|
Kidney Diseases
|
0.100 |
AlteredExpression
|
group |
LHGDN |
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
|
17984105 |
2008 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
To determine whether adiponectin, an adipocyte-derived hormone, is a communication signal between adipocytes and the kidney, we performed studies in a cohort of patients at high risk for diabetes and kidney disease as well as in adiponectin-knockout (Ad(-/-)) mice.
|
18431508 |
2008 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
These findings suggest that adiponectin is a biomarker for kidney disease and may be targeted for prevention and treatment.
|
18431507 |
2008 |
|
Kidney Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The T-allele of SLC2A2_16459CT was associated with a decreased risk of diabetic nephropathy (odds ratio 0.79 [95% CI 0.66-0.96], P = 0.016), whereas the T-allele of KNG_7965CT and the A-allele of ADIPOQ_prom2GA were associated with increased risk of nephropathy (1.17 [1.03-1.32], P = 0.016; 1.46 [1.11-1.93], P = 0.006, respectively).
|
17065357 |
2006 |
|
Kidney Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.
|
14675060 |
2004 |